Insider Transactions in Q4 2022 at Fibrogen Inc (FGEN)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2022
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
734
-0.82%
|
$11,010
$15.8 P/Share
|
|
Dec 12
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,407
-2.55%
|
$19,698
$14.5 P/Share
|
|
Dec 09
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
781
-1.4%
|
$10,934
$14.9 P/Share
|
|
Dec 08
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,741
-5.18%
|
$86,115
$15.16 P/Share
|
|
Dec 08
2022
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
382
-0.42%
|
$5,730
$15.79 P/Share
|
|
Dec 08
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,543
-0.85%
|
$38,145
$15.79 P/Share
|
|
Dec 08
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
1,096
-0.46%
|
$16,440
$15.79 P/Share
|
|
Dec 01
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-0.76%
|
$16,260
$15.04 P/Share
|
|
Oct 06
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,296
-0.43%
|
$18,144
$14.26 P/Share
|